<DOC>
	<DOCNO>NCT01532830</DOCNO>
	<brief_summary>The purpose pilot study assess feasibility clarify design future study ( y ) support marketing approval GammaCore™ device treatment and/or prevention migraine symptom .</brief_summary>
	<brief_title>Non-Invasive Neurostimulation For Relief Symptoms Associated With Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Is age 18 55 year . Has previously diagnose suffer migraine , accordance ICHD2 Classification criterion ( 2nd ) , without aura . Experiences least 2 migraine per month , less 15 headache day per month ( last 3 month ) . Has age onset migraine le 50 year old . Is able give write Informed Consent Has history aneurysm , intracranial hemorrhage , brain tumor significant head trauma . Has lesion ( include lymphadenopathy ) GammaCore™ treatment site . Has know suspect severe atherosclerotic cardiovascular disease , severe carotid artery disease ( e.g . bruits history TIA CVA ) , congestive heart failure ( CHF ) , coronary artery disease recent myocardial infarction . Has history baseline ECG identify presence clinically significant unstable cardiac arrhythmia , second degree heart block type II , history ventricular tachycardia ventricular fibrillation , know cardiac syndrome may associate increase risk sudden death otherwise healthy people . Has previous bilateral right cervical vagotomy . Has clinically significant irregular heart rate rhythm . Has uncontrolled high blood pressure . Is currently implanted electrical and/or neurostimulator device , include limited cardiac pacemaker , vagal neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator , cochlear implant . Has history carotid endarterectomy vascular neck surgery right side . Has implant metal cervical spine hardware metallic implant near GammaCore™ stimulation site . Has recent repeat history syncope . Has recent repeat history seizure . Has history suspicion narcotic abuse . Takes medication acute headaches 10 day per month . Is pregnant , nursing , think become pregnant next 3 month , childbearing year unwilling use accept form birth control . Is participate therapeutic clinical investigation participate clinical trial precede 30 day . Belongs vulnerable population condition ability provide inform consent , comply followup requirement , provide selfassessments compromise ( e.g. , homeless , developmentally disabled , prisoner ) . Is relative employee investigator clinical study site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>vagus nerve stimulation</keyword>
	<keyword>vagal nerve stimulation</keyword>
	<keyword>nVNS</keyword>
	<keyword>VNS</keyword>
	<keyword>migraine</keyword>
	<keyword>non invasive</keyword>
	<keyword>gammacore</keyword>
</DOC>